Fresenius Medical Care AG has the GF Score of 50, which implies that the company
might have
Worst future performance potential, or not enough data.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Fresenius Medical Care AG
might have
Worst future performance potential, or not enough data.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Fresenius Medical Care AG (MEX:FME N) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Fresenius Medical Care AG GF Score Related Terms
MEX:FME N vs HCA, THC, DVA: GF Score Comparison
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG GF Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's GF Score distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's GF Score falls into.
Fresenius Medical Care AG (MEX:FME N) has a GF Score of 50 as of Jul. 05, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Fresenius Medical Care AG and its competitors. This is 32% below median its historical median of 73.00. Over the past decade, Fresenius Medical Care AG's GF Score has ranged from 16.00 to 96.00.
Is Fresenius Medical Care AG's GF Score too high?
Fresenius Medical Care AG's current GF Score of 50 is 32% below median its 10-year median of 73.00. Over the past 10 years, this metric has ranged from a low of 16.00 to a high of 96.00. Overall, Fresenius Medical Care AG has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's GF Score compare to HCA and THC?
Fresenius Medical Care AG's GF Score of 50 can be compared against companies in the Healthcare Providers & Services industry. Historically, Fresenius Medical Care AG's own GF Score has ranged from 16.00 to 96.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Healthcare Providers & Services company?
A good GF Score depends on the Healthcare Providers & Services industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current GF Score is 50, which is 32% below median its own 10-year median of 73.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (MEX:FME N) is currently considered Possible Value Trap. The stock's GF Value™ is MXN782.87, compared to a current price of MXN778.14 — trading 0.6% below its estimated fair value. The current GF Score is 50, which is 32% below median its 10-year median of 73.00. Fresenius Medical Care AG's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Fresenius Medical Care AG (MEX:FME N), the current GF Score is 50 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (MEX:FME N) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued.
The current stock price of MXN778.14 is trading 0.6% below its estimated GF Value™ of MXN782.87.
GuruFocus considers Fresenius Medical Care AG to be Possible Value Trap.
Key valuation signals for MEX:FME N:
GF Score: 50 (32% below median its 10-year median of 73.00)
GF Value™: MXN782.87 vs. price of MXN778.14 (0.6% below fair value)
No single metric tells the full story. See the MEX:FME N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
50GF Score
Get the complete analysis for MEX:FME N
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:FME N has been successfully added to your 